Physicians debate best management strategy for patient with benign prostatic hyperplasia

In a new Annals ‘Beyond the Guidelines’ feature, a general internal medicine physician and a urologist discuss treatment options for benign prostatic hyperplasia (BPH) and how they would apply their recommendations to a patient who wishes to learn more about his options. All ‘Beyond the Guidelines’ features are based on the Department of Medicine Grand Rounds at Beth Israel Deaconess Medical Center (BIDMC) in Boston and include print, video, and educational components published in Annals of Internal Medicine.

Medications for enlarged prostate linked to heart failure risk

Widely used medications for benign prostatic hyperplasia (BPH) – also known as enlarged prostate – may be associated with a small, but significant increase in the probability of developing heart failure, suggests a study in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.